Cargando…
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
We describe a strategy to comprehend signaling pathways active in lung cancer cells and targeted by dasatinib employing chemical proteomics to identify direct interacting proteins combined with immunoaffinity purification of tyrosine phosphorylated peptides corresponding to activated tyrosine kinase...
Autores principales: | Li, Jiannong, Rix, Uwe, Fang, Bin, Bai, Yun, Edwards, Arthur, Colinge, Jacques, Bennett, Keiryn L., Gao, Jingchun, Song, Lanxi, Eschrich, Steven, Superti-Furga, Giulio, Koomen, John, Haura, Eric B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842457/ https://www.ncbi.nlm.nih.gov/pubmed/20190765 http://dx.doi.org/10.1038/nchembio.332 |
Ejemplares similares
-
Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms
por: Li, Jiannong, et al.
Publicado: (2013) -
A Computational Approach to Analyze the Mechanism of Action of the Kinase Inhibitor Bafetinib
por: Burkard, Thomas R., et al.
Publicado: (2010) -
A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph+ ALL
por: Rix, Uwe, et al.
Publicado: (2013) -
Initial characterization of the human central proteome
por: Burkard, Thomas R, et al.
Publicado: (2011) -
Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer
por: Mishall, Katie M., et al.
Publicado: (2017)